JAK2 and nasopharyngeal carcinoma: As the upstream activator of the JAK2/STAT3 pathway, the increased expression of IL-6 and the activation of JAK2/STAT3 signaling pathway have an impact on the prognosis of patients with NPC, shortening the survival time and providing potential targets for the treatment of NPC.6